These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22587530)

  • 1. Sildenafil for COPD: a randomized crossover trial.
    Bull T; Badesch DB
    COPD; 2012 Jun; 9(3):211-2. PubMed ID: 22587530
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial.
    Lederer DJ; Bartels MN; Schluger NW; Brogan F; Jellen P; Thomashow BM; Kawut SM
    COPD; 2012 Jun; 9(3):268-75. PubMed ID: 22360383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil: a definitive NO in COPD.
    Vonk-Noordegraaf A; Boerrigter BG
    Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we administer sildenafil to patients with obstructive pulmonary disease and pulmonary hypertension? No.
    Namendys-Silva SA; Hernández-Garay M
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1206; author reply 1206-7. PubMed ID: 21041564
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD.
    Holverda S; Rietema H; Bogaard HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Pulm Pharmacol Ther; 2008; 21(3):558-64. PubMed ID: 18342559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
    Blanco I; Santos S; Gea J; Güell R; Torres F; Gimeno-Santos E; Rodriguez DA; Vilaró J; Gómez B; Roca J; Barberà JA
    Eur Respir J; 2013 Oct; 42(4):982-92. PubMed ID: 23429918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sildenafil influence on the level of pulmonary artery pressure, bronchial patency and endothelial function during the action of risk factors for development of cardiorespiratory pathology].
    Baksheev VI; Kolomoets NM; Kartashov VT; Tursunova GF
    Voen Med Zh; 2006 Dec; 327(12):21-3. PubMed ID: 17338363
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil.
    Guazzi M; Myers J; Peberdy MA; Bensimhon D; Chase P; Arena R
    Int J Cardiol; 2010 Oct; 144(3):410-2. PubMed ID: 19329196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective vasodilation in the lung. Sildenafil improves physical capacity and prognosis].
    MMW Fortschr Med; 2007 May; 149(22):45. PubMed ID: 18069228
    [No Abstract]   [Full Text] [Related]  

  • 11. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity.
    Rietema H; Holverda S; Bogaard HJ; Marcus JT; Smit HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Eur Respir J; 2008 Apr; 31(4):759-64. PubMed ID: 18094009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication.
    Roseguini BT; Hirai DM; Alencar MC; Ramos RP; Silva BM; Wolosker N; Neder JA; Nery LE
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R396-404. PubMed ID: 24944249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil may facilitate weaning in mechanically ventilated COPD patients: a report of three cases.
    Stanopoulos I; Manolakoglou N; Pitsiou G; Trigonis I; Tsiata EA; Boutou AK; Kontou PK; Argyropoulou P
    Anaesth Intensive Care; 2007 Aug; 35(4):610-3. PubMed ID: 18020085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease.
    Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ
    Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil in idiopathic pulmonary fibrosis.
    Rossi GP; Seccia TM
    N Engl J Med; 2010 Nov; 363(22):2169-70; author reply 2170-1. PubMed ID: 21105803
    [No Abstract]   [Full Text] [Related]  

  • 17. Sildenafil in idiopathic pulmonary fibrosis.
    Mubarak K
    N Engl J Med; 2010 Nov; 363(22):2170; author reply 2170-1. PubMed ID: 21105802
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of sildenafil on respiratory weaning of patients with chronic obstructive pulmonary diseases admitted to intensive care unit.
    Rafiei MR; Aghadavoudi O; Hojjat M
    Med Arh; 2012; 66(2):104-6. PubMed ID: 22486141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sildenafil in an experimental model of ischemic colitis.
    Medhi B; Kaur H; Prakash A
    Dig Dis Sci; 2009 Feb; 54(2):419. PubMed ID: 18975075
    [No Abstract]   [Full Text] [Related]  

  • 20. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
    Hill NS; Preston IR; Roberts KE
    Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.